The Relaxant Activity of 4,7-Dimethyl-1,2,5-oxadiazolo[3,4-d]-pyridazine 1,5,6-Trioxide in the Mouse Corpus Cavernosum
- Cemil Göçmen,
- H. Sinem Büyüknacar,
- Alexander Ya Kots,
- Ferid Murad,
- Olcay Kiroğlu and
- Eda Karabal Kumcu
- Department of Pharmacology, Çukurova University Medical School, Adana, Turkey (C.G., H.S.B., O.K., E.K.K.); and Department of Integrative Biology and Pharmacology, The University of Texas at Houston Medical School, Houston, Texas (A.Y.K., F.M.)
- Address correspondence to:
Dr. Cemil Göçmen, Department of Pharmacology, Çukurova University Medical School, TR-01330 Adana, Turkey. E-mail: cgocmen{at}cu.edu.tr
Abstract
We have studied the effect of an activator of soluble guanylate cyclase 4,7-dimethyl-1,2,5-oxadiazolo[3,4-d]pyridazine 1,5,6-trioxide (FPTO) on the tone and nitrergic relaxation responses of mouse cavernous strips and compared FPTO to a known nitric oxide donor sodium nitroprusside. FPTO thiol-dependently generated nitric oxide measured by polarography and activated purified human soluble guanylate cyclase. FPTO and sodium nitroprusside relaxed the cavernous tissue in a concentration-dependent manner. A nitric-oxide synthase inhibitor Nω-nitro-l-arginine did not alter the relaxations to FPTO or sodium nitroprusside, whereas soluble guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) suppressed relaxation to FPTO and sodium nitroprusside. Exogenously added thiols l-cysteine or dithiothreitol inhibited the relaxant responses to FPTO but not to sodium nitroprusside, whereas glutathione did not influence the responses to both agents. Thiol alkylation agent N-ethylmaleimide significantly enhanced FPTO-induced relaxation, and thiol-modifying agent diamide inhibited relaxation to FPTO. The potentiating effect of N-ethylmaleimide was neutralized by coadministration of N-ethylmaleimide with glutathione, l-cysteine, dithiothreitol, or ODQ. N-Ethylmaleimide but not diamide significantly inhibited relaxation induced by sodium nitroprusside. FPTO potently suppressed contraction to electrical field stimulation, which was prevented by glutathione or l-cysteine. In addition, FPTO did not affect relaxation produced by electrical field stimulation in phenylephrine-precontracted tissue. Our results show that FPTO can relax mouse corpus cavernosum and that the relaxant activity of this agent is thiol- and soluble guanylate cyclase-dependent. This effect could be potentiated by N-ethylmaleimide. FPTO does not potentiate nitrergic relaxation induced by electrical field stimulation.
Footnotes
-
doi:10.1124/jpet.105.094250.
-
ABBREVIATIONS: sGC, soluble guanylate cyclase; NO, nitric oxide; YC-1, 3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole; BAY41-2272, 5-cy-clopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-yl amine; FPTO, 4,7-dimethyl-1,2,5-oxadiazolo[3,4-d]pyridazine 1,5, 6-trioxide; ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one; SNP, sodium nitroprusside.
-
- Received August 15, 2005.
- Accepted October 26, 2005.
- The American Society for Pharmacology and Experimental Therapeutics



